Gentamicin Injection, Solution
Product Images NDC 0404-9866

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gentamicin (NDC 0404-9866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure diagram of gentamicin sulfate, showing the core molecular structure with variable groups labeled as C1, C2, and C2a. The image illustrates the different components of the gentamicin molecule related to the active ingredient gentamicin sulfate.*

FDA Label Image

Label1.jpg (Label1)

Gentamicin 600 mg per 20 mL injection, USP multiple dose vial label. The solution is for intramuscular or intravenous use and must be diluted for IV use. The label includes storage instructions (20 to 25°C) and a warning about close clinical observation due to potential toxicity. It is packaged by Henry Schein, Inc. with an NDC of 0404-9866-20.*

FDA Label Image

Table1.jpg (Table1)

A data table titled 'Susceptibility Interpretive Criteria for Gentamicin' showing breakpoint values for minimal inhibitory concentration (mcg/mL) and zone diameter (mm) across three pathogen groups: Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus species. The table categorizes susceptibility as susceptible (S), intermediate (I), or resistant (R) based on these values.*

FDA Label Image

Table2.jpg (Table2)

A data table titled 'Acceptable Quality Control Ranges for Gentamicin' listing quality control organisms, minimum inhibitory concentrations (mcg/mL), and zone diameters (mm). Organisms include Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus (two strains), and Enterococcus faecalis, with corresponding concentration ranges and zone diameter values or not applicable notes.*

FDA Label Image

Table3.jpg (Table3)

A dosing chart table for Gentamicin Sulfate injection, solution showing recommended doses based on patient weight in kg and lbs. The table includes usual doses for serious infections (1 mg/kg q8h or 3 mg/kg/day) and doses for life-threatening infections (1.7 mg/kg q8h or 5 mg/kg/day), with columns for mg/dose, ml/dose, and q8h frequency.*

FDA Label Image

Table4.jpg (Table4)

A data table showing dosage adjustments for Gentamicin injection based on serum creatinine levels and approximate creatinine clearance rates. The table lists ranges of serum creatinine (mg %) alongside the corresponding creatinine clearance rate (mL/min/1.73m2) and the recommended percentage of usual doses to be administered.*

FDA Label Image

Table5.jpg (Table5)

A table listing product codes, unit of sale, strength, and packaging details for Gentamicin injection. It includes two entries: one with 80 mg per 2 mL (40 mg/mL) in 2 mL multiple dose vials sold in units of 25, and another with 800 mg per 20 mL (40 mg/mL) in 20 mL multiple dose vials also sold in units of 25.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.